Aducanumab: A Deep Dive into BIIB037 and its Impact The medication, initially known as BIIB037, constitutes a complex attempt to combat emerging Alzheimer's illness. Designed by Biogen, the treatment functions by https://www.targetmol.com/compound/aducanumab